Bioactivation of CB 1954: Reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species

This publication has 11 references indexed in Scilit:

• The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide)
  Biochemical Pharmacology, 1991
• The nitroreductase enzyme in walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-YL)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)
  Biochemical Pharmacology, 1988
• A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in walker carcinoma cells
  Biochemical Pharmacology, 1988
• Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: Relationship to toxicity
  Pharmacology & Therapeutics, 1987
• CB 1954 revisited
  Cancer Chemotherapy and Pharmacology, 1986
• CB 1954 revisited
  Cancer Chemotherapy and Pharmacology, 1986
• The binding of N-hydroxy-2-acetylaminofluorene to DNA and repair of the adducts in primary rat hepatocyte cultures
  Carcinogenesis: Integrative Cancer Research, 1981
• The metabolism of the anti-tumour agent 5-(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954)
  Biochemical Pharmacology, 1976
• Seryl-tRNA synthetase and activation of the carcinogen 4-nitroquinoline 1-oxide
  Nature, 1975
• 2,4-Dinitro-5-ethyleneiminobenzamide (CB 1954): A potent and selective inhibitor of the growth of the Walker carcinoma 256
  Biochemical Pharmacology, 1969